Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 136

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 2
Chunk 136
---
 Chief Executive Officer) considers to be non-operational, such as Interest and other financial charges – net, Benefit (provision) for income taxes, restructuring costs, acquisition and disposition-related benefits (charges), Spin-Off and separation costs, Non-operating benefit (income) costs, gain (loss) on business and asset dispositions, amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, and investment revaluation gain (loss). See Note 3, “Segment Information” for additional information on our reportable segments, and “Results of Operations” above for discussion on segment revenue performance.

Segment EBITFor the three months ended September 30For the nine months ended September 302025% of segment revenues2024% of segment revenues% change2025% of segment revenues2024% of segment revenues % changeImaging    $24010.2 %$28712.9 %(16)%$6279.4 %$66010.2 %(5)%AVS27120.9 %23219.0 %17 %79920.9 %74420.2 %7 %PCS    273.7 %8210.6 %(67)%1356.0 %24110.5 %(44)%PDx    22029.4 %19330.9 %14 %63830.3 %57130.6 %12 %

____________________

*Non-GAAP Financial Measure

36

For the three months ended September 30, 2025

•Imaging Segment EBIT was $240 million, a decrease of $46 million due to cost inflation, including the impact of incremental tariffs, partially offset by a growth in sales volume;

•AVS Segment EBIT was $271 million, an increase of $40 million due to growth in sales volume and cost productivity, partially offset by cost inflation, including the impact of incremental tariffs;

•PCS Segment EBIT was $27 million, a decrease of $55 million due to a decline in sales volume, cost inflation, including the impact of incremental tariffs, and unfavorable mix; and

•PDx Segment EBIT was $220 million, an increase of $27 million due to an increase in price and growth in sales volume, partially offset by increased investment.

For the nine months ended September 30, 2025

•